Monday, April 8, 2019
Nine rapid fire presentations on the applications of AI in Clinical Care
Applying AI to Save Lives During the Opioid Crisis
The U.S. is in the throes of a devastating epidemic of opioid addiction and overdose — some 130 people die in this country every day from opioids, says the National Institute on Drug Abuse. With a total economic cost of more than $78 billion a year, academic and industry organizations are harnessing AI to develop new tools that can help alleviate this national crisis. This session will discuss some of the AI-based strategies that academic and industry teams are leveraging to help clinical and public health officials better predict, identify, and treat opioid addiction, as well as some of the concerns around data privacy.
Moderator: Thomas Sequist, MD, Chief Quality & Safety Officer, PHS
Bob Burgin, CEO, Amplifire Healthcare Alliance
Carm Huntress, CEO, RxRevu Inc
Sarah Wakeman, MD, Medical Director, Substance Use Disorder Initiative, MGH; Assistant Professor, Medicine, HMS
Scott Weiner, MD, Director, Brigham Comprehensive Opioid Response and Education (B-CORE) Program, BWH; Assistant Professor, HMS
Community Hospitals: Key Component in Healthcare Transformation
Community hospitals are the largest sources of patient care in the U.S. As such, they represent a critical frontier in the transformation of health care. How are these organizations using AI and digital technologies to drive transformation? What are the key distinctions from academic medical centers? This session will address these and other critical topics that impact community hospitals and their essential, though often overlooked, role in health care.
Moderator: Michael Jaff, DO, President, NWH, PHS, Professor of Medicine, HMS
Fabien Beckers, PhD, CEO, Arterys
Joanna Geisinger, CEO, TORq Interface
John Miller, MD, Director, Retinal Imaging, MEE; Assistant Professor, Ophthalmology, HMS
Lee Schwamm, MD, Director, Center for TeleHealth and Exec Vice Chair, Neurology, MGH; Professor, Neurology, HMS
Tal Wenderow, CEO, Beyond Verbal
Digital Management of Diabetes
Across the full spectrum of patient care, the management of diabetes has been flooded with new technology and treatment options for both type 1 and type 2 diabetes – there is a range of new devices and software, including automatic insulin infusion systems, glucose sensors, AI-based algorithms and decision support tools, with artificial pancreas on the horizon. This session will focus on these areas as well as clinical use cases that highlight the value of AI.
Moderator: Deborah Wexler, MD, Clinical Director, Diabetes Center, MGH; Associate Professor, HMS
Marie McDonnell, MD, Section Chief and Director, Diabetes Program, BWH; Lecturer, HMS
Joshua Riff, MD, CEO, Onduo
Mental Health and the Promise of AI
Moderator: Sabine Wilhelm, PhD, Chief of Psychology; Director, OCD and Related Disorders Program, MGH; Professor, Psychology, HMS
Thomas McCoy, MD, Director of Research, Center for Quantitative Health, MGH; Assistant Professor, Psychiatry & Medicine, HMS
Christopher Molaro, CEO, Neuroflow
David Silbersweig, MD, Chairman, Department of Psychiatry, BWH; Stanley Cobb Professor of Psychiatry, HMS
From Startup to Impact (Pharma and Diagnostics)
With all the hype surrounding AI, this session will focus on what really matters. Impact! Who is really moving the needle in life sciences today? This session will introduce you to five leading companies who will share their client stories over lunch.
Moderator: James Brink, MD, Radiologist-in-Chief, MGH; Juan M. Taveras Professor of Radiology, HMS
Alex Zharavoronkov, PhD, CEO, Insilico Medicine, Inc
Cardiovascular diseases remain the leading cause of death worldwide and a major source of health care spending, making this area ripe for AI-enabled innovations. Teams in academia and industry are pursuing a range of AI-based tools in cardiovascular medicine: from AI-powered drug discovery and diagnostics to automated cardiac image analyses and AI-guided care delivery pathways. Panelists will discuss these and other areas where AI is having a sizeable impact; the discussion will also include the perspectives of a patient who benefited from AI-enabled cardiovascular care.
Tuesday, April 9, 2019
In 1984 Isaac Asimov was asked to predict what life in 2019 would be like. Using the same aperture, we as what will health care look like 35 years from now? What capabilities will clinicians have that they now struggle with? And what will be the biggest challenges? Current trends suggest that we will see some significant gains in the areas of cancer immunotherapy, gene therapy for devastating rare diseases, and treatments for common neuropsychiatric conditions, including schizophrenia and depression. Panelists will draw on their visionary perspective and will reflect on what to expect and why.
Back Office of the Provider Future
Moderator: Peter Markell, EVP, Administration and Finance, CFO and Treasurer, PHS
Kent Ivanoff, CEO, VisitPay
Connie Moser, Chief Operating Officer, Verge Health
Brian Robertson, CEO, VisiQuate
Chief Digital Strategy Officer Roundtable
With the advent of healthcare AI-enabled technologies, this session brings together several chief digital health officers from a range of organizations. The discussion will address key tradeoffs in sequencing technology across academic medical centers; what technologies are being prioritized; and how consumer expectations are impacting the future delivery model of healthcare.
Moderator: Alistair Erskine, MD, Chief Digital Health Officer, PHS
Michael Anderes, Chief Innovation and Digital Health Officer, Froedtert Health; President, Inception Health
Adam Landman, MD, VP and CIO, Brigham Health; Associate Professor of Emergency Medicine, HMS
Aimee Quirk, CEO, innovationOchsner
Richard Zane, MD, Chief Innovation Officer, UCHealth; Professor and Chair,Department of Emergency Medicine, University of Colorado School of Medicine
Innovation Fellows: A New Model of Collaboration
The Innovation Fellows Program provides short-term, experiential career development opportunities for future leaders in health care focused on accelerating collaborative innovation between science and industry. It facilitates personnel exchanges between Harvard Medical School staff from Partners’ hospitals and participating biopharmaceutical, device, venture capital, digital health, payor and consulting firms. A successful example of open innovation, Fellows and Hosts learn from each other as they collaborate on projects ranging from clinical development to digital health & artificial intelligence to new care delivery models and industry disruption. Come listen to the experience and insights of our panelists, including Fellows, Industry Partners and hospital leadership, and learn how this new model of collaboration can deliver value and lead to broader relationships between industry and academia.
Moderator: Seema Basu, PhD, Market Sector Leader, Innovation, PHS
Peter Ho, MD, PhD, CMO, Boston Pharmaceuticals
Harry Orf, PhD, SVP, Research, MGH; Principal Associate, HMS
Last Mile: Fully Implementing AI in Healthcare
This session will focus on how radiology and pathology specialties are currently applying AI in the clinic. Where will it be built out first? What are the barriers and how will these challenges be overcome?
Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS
Samuel Aronson, Executive Director, IT, Personalized Medicine, PHS
Seth Hain, VP of R&D, Epic
Jonathan Teich, MD, PhD, Chief Medical Information Officer, InterSystems; Emergency Medicine, BWH
Reimagining Disease Management
Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS
Murray Brozinsky, Chief Strategy Officer, Conversa
Jean Drouin, MD, CEO, Clarify Health Solutions
Sandhya Rao, MD, Senior Medical Director, Population Health, PHS; Assistant Professor, Medicine, HMS
Standards and Regulation: The Emerging AI Framework
Moderator: Brent Henry, Member, Mintz Levin
Bethany Hills, Member/ Chair, FDA Practice, Mintz Levin
From Startup to Impact (Provider Solutions)
With all the hype surrounding AI, this session will focus on what really matters. Impact! Who is really moving the needle for healthcare providers today? This session will introduce you to five leading companies who will share their client stories over lunch.
Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS
Wednesday, April 10, 2019
Twelve clinical AI teams culled through the Innovation Discovery Grant program present their work illustrating how AI can be used to improve patient health and healthcare delivery. This session is designed for investors, entrepreneurs, investigators, and others who are interested in commercializing AI opportunities that are currently in development with support from the Innovation Office.
The culture of innovation throughout Partners HealthCare naturally fosters robust discussions about new “disruptive” technologies and which ones will have the biggest impact on health care. The Disruptive Dozen was created to identify and rank the technologies that Partners faculty feel will break through over the next decade to significantly improve health care. This year, the Disruptive Dozen focuses on relevant advances and opportunities in artificial intelligence (AI).